Search by Drug Name or NDC
NDC 00781-3411-95 Anectine 20 mg/mL Details
Anectine 20 mg/mL
Anectine is a INTRAMUSCULAR; INTRAVENOUS; PARENTERAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is SUCCINYLCHOLINE CHLORIDE.
Product Information
| NDC | 00781-3411 |
|---|---|
| Product ID | 0781-3411_1608ee20-304e-4f78-a9ba-4d067836cdb5 |
| Associated GPIs | 74100010102005 |
| GCN Sequence Number | 004676 |
| GCN Sequence Number Description | succinylcholine chloride VIAL 20 MG/ML INJECTION |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 17992 |
| HICL Sequence Number | 001948 |
| HICL Sequence Number Description | SUCCINYLCHOLINE CHLORIDE |
| Brand/Generic | Brand |
| Proprietary Name | Anectine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Succinylcholine Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | SUCCINYLCHOLINE CHLORIDE |
| Labeler Name | Sandoz Inc |
| Pharmaceutical Class | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA008453 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00781-3411-95 (00781341195)
| NDC Package Code | 0781-3411-95 |
|---|---|
| Billing NDC | 00781341195 |
| Package | 10 VIAL, MULTI-DOSE in 1 CARTON (0781-3411-95) / 10 mL in 1 VIAL, MULTI-DOSE (0781-3411-70) |
| Marketing Start Date | 2017-06-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |